Literature DB >> 18547625

Toll-like receptor heterodimer variants protect from childhood asthma.

Michael S D Kormann1, Martin Depner, Dominik Hartl, Norman Klopp, Thomas Illig, Jerzy Adamski, Christian Vogelberg, Stephan K Weiland, Erika von Mutius, Michael Kabesch.   

Abstract

BACKGROUND: Early exposure to microbes reduces the risk for asthma. Toll-like receptors (TLRs) represent a major group of receptors for the specific recognition of pathogen-associated molecular patterns of microbes capable of activating innate and adaptive immunity.
OBJECTIVE: Because TLRs can influence key events in the induction and perpetuation of asthma and atopy, we sought to determine whether genetic alterations in TLR genes affect asthma risk.
METHODS: We systematically evaluated putatively functional genetic variants in all 10 human TLR genes for their association with different asthma phenotypes in a case-control study (n = 1872) by using matrix-assisted laser desorption/ionization time-of-flight genotyping. For polymorphisms showing association with atopic asthma, effects on gene and protein expression were studied by means of RT-PCR and flow cytometry ex vivo. T-cell cytokine production was evaluated by means of ELISA after stimulation of the respective TLRs with specific ligands.
RESULTS: Protective effects on atopic asthma were identified for single nucleotide polymorphisms in TLR1 (odds ratio [OR], 0.54; 95% CI, 0.37-0.81; P = .002), TLR6 (OR, 0.54; 95% CI, 0.37-0.79; P = .003), and TLR10 (OR, 0.58; 95% CI, 0.39-0.86; P = .006), all capable of forming heterodimers with TLR2. Effects remained significant after correction for multiple comparisons. PBMCs of minor allele carriers showed increased levels of the respective TLR mRNA and proteins, augmented inflammatory responses, increased T(H)1 cytokine expression, and reduced T(H)2-associated IL-4 production after specific stimulation.
CONCLUSION: These results suggest that functional relevant TLR1 and TLR6 variants are directly involved in asthma development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547625     DOI: 10.1016/j.jaci.2008.04.039

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  56 in total

Review 1.  Dangerous allergens: why some allergens are bad actors.

Authors:  Steve N Georas; Fariba Rezaee; Laurie Lerner; Lisa Beck
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

2.  The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A.

Authors:  Ana Paula Moreira; Karen A Cavassani; Ugur B Ismailoglu; Rikki Hullinger; Michael P Dunleavy; Darryl A Knight; Steven L Kunkel; Satoshi Uematsu; Shizuo Akira; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 3.  International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease.

Authors:  Clare E Bryant; Selinda Orr; Brian Ferguson; Martyn F Symmons; Joseph P Boyle; Tom P Monie
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

4.  Role of infections in the induction and development of asthma: genetic and inflammatory drivers.

Authors:  Qun Wu; Hong Wei Chu
Journal:  Expert Rev Clin Immunol       Date:  2009-01-01       Impact factor: 4.473

5.  Urban-rural differences in the gene expression profiles of Ghanaian children.

Authors:  A S Amoah; B B Obeng; L May; Y C Kruize; I A Larbi; M Kabesch; M D Wilson; F C Hartgers; D A Boakye; M Yazdanbakhsh
Journal:  Genes Immun       Date:  2014-05-22       Impact factor: 2.676

6.  Secreted phosphoprotein 1 is a determinant of lung function development in mice.

Authors:  Koustav Ganguly; Timothy M Martin; Vincent J Concel; Swapna Upadhyay; Kiflai Bein; Kelly A Brant; Leema George; Ankita Mitra; Tania A Thimraj; James P Fabisiak; Louis J Vuga; Cheryl Fattman; Naftali Kaminski; Holger Schulz; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

7.  Unraveling the genetic basis of asthma and allergic diseases.

Authors:  Jian-Feng Meng; Lanny J Rosenwasser
Journal:  Allergy Asthma Immunol Res       Date:  2010-06-11       Impact factor: 5.764

8.  Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs.

Authors:  Martina Barrenschee; Dennis Lex; Stefan Uhlig
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

Review 9.  Advances in mechanisms of asthma, allergy, and immunology in 2008.

Authors:  Joshua A Boyce; David Broide; Kenji Matsumoto; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2009-03       Impact factor: 10.793

10.  Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: a candidate gene association study.

Authors:  Callie M Thompson; Tarah D Holden; Gail Rona; Balaji Laxmanan; R Anthony Black; Grant E OʼKeefe; Mark M Wurfel
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.